High caffeine levels associated with weight loss and type 2 diabetes risk: BMJ

Published Date: 17 Mar 2023

UK: A recent study published in BMJ Medicine found that more caffeine in the blood can reduce the risk of type 2 diabetes and obesity. more...

Read Full News

Latest News

Protein Source Key for Weight Loss After Menopause

Postmenopausal women are often encouraged to eat more protein, but a new study finds that protein source matters, with plant-based protein outperforming animal protein for weight loss.

What GLP-1s Are Teaching Us About Compulsive Behavior

As GLP-1 research moves deeper into the brain, scientists are asking whether these drugs can help explain why some urges become so hard to resist.

Fasting and Calorie Restriction Work via Different Pathways

In adults with obesity, both intermittent fasting and calorie restriction lead to significant weight loss but act through distinct behavioral pathways.

GLP-1s Tied to Reduced Opioid Use in Chronic Pancreatitis

Among patients with chronic pancreatitis, GLP‑1 treatment is associated with a lower likelihood of initiating long-term opioid therapy or developing opioid use disorder.

NHS Recommends First Drug to Delay Type 1 Diabetes

NICE has recommended teplizumab — the first medicine to delay type 1 diabetes onset — in what Diabetes UK calls ‘a new age of treatment.’

GLP-1 Era Demands a New Model of Obesity Care

Panelists at HLTH Europe 2026 say obesity care must shift to lifelong digital models and shed its stigma as a moral failing.

Todays Updates

Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?

Drug holidays are proving possible in hormone-sensitive metastatic prostate cancer — and some men stay off treatment for years.

CAR T Cells Produce 10-Year Remissions in Some With Lymphoma

Researchers evaluated long-term outcomes in patients with relapsed or refractory B-cell non-Hodgkin lymphomas receiving CAR T-cell therapy.

Todays Updates

Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?

Drug holidays are proving possible in hormone-sensitive metastatic prostate cancer — and some men stay off treatment for years.

CAR T Cells Produce 10-Year Remissions in Some With Lymphoma

Researchers evaluated long-term outcomes in patients with relapsed or refractory B-cell non-Hodgkin lymphomas receiving CAR T-cell therapy.

Latest News

Postmenopausal women are often encouraged to eat more protein, but a new study finds that protein source matters, with plant-based protein outperforming animal protein for weight loss.

As GLP-1 research moves deeper into the brain, scientists are asking whether these drugs can help explain why some urges become so hard to resist.

In adults with obesity, both intermittent fasting and calorie restriction lead to significant weight loss but act through distinct behavioral pathways.

Among patients with chronic pancreatitis, GLP‑1 treatment is associated with a lower likelihood of initiating long-term opioid therapy or developing opioid use disorder.

NICE has recommended teplizumab — the first medicine to delay type 1 diabetes onset — in what Diabetes UK calls ‘a new age of treatment.’

Panelists at HLTH Europe 2026 say obesity care must shift to lifelong digital models and shed its stigma as a moral failing.

News All Time

Tirzepatide Tops Semaglutide in Real-World Weight Loss

Tirzepatide leads to greater and faster weight loss than semaglutide in a real-world analysis of more than 20,000 patients with obesity.

GLP-1s Could Help Improve Symptoms of PMOS

The metabolic symptoms of PMOS, including overweight and diabetes, may be effectively treated by GLP-1s.

Are GLP-1s Increasing Eating Disorder Risk?

With GLP-1s readily available, some experts fear misuse is increasing and may be fueling eating disorders. Physicians describe what they are seeing and how they manage the risks.

US FDA Sends 25 Letters to Telehealth Companies Over Claims on Compounded Weight-loss Drugs

The U.S. Food and Drug Administration issued 25 warning letters to telehealth companies for marketing false and misleading claims about ⁠compounded versions of Eli Lilly and...

Sitting Less, More Light Activity May Reduce Pregnancy Risks

Pregnant individuals who sit for more than 10 hours daily face higher risks for adverse pregnancy outcomes, whereas about 7 hours of light-intensity activity daily is linked to a lower risk.

Support Groups Boost Weight Loss in Patients With Obesity

Consistent engagement in a support group paired with lifestyle changes has been shown to be linked to notably greater weight loss in a community gastroenterology clinic weight-management program.

GLP-1s Tied to Lower Cancer Risk in Patients With Obesity

In a large observational study of adults with obesity without diabetes, GLP-1 receptor agonists were associated with a 41% lower incidence of obesity-associated cancers over 2 years.

German Government to Abandon Variable Drug Discounting Plans, Source Tells Reuters

Germany's government is replacing plans that would have introduced variable discounts on pharmaceuticals, ⁠a government source told Reuters on Monday, following opposition...

Male Fertility Not Harmed by GLP-1s and Maybe Helped

A systematic review finds no consistent adverse effects on the male hypothalamic-pituitary-gonadal axis and some evidence of fertility improvement with GLP-1 use.

Tirzepatide May Reverse Postbariatric Weight Regain

Tirzepatide treatment yields substantial weight loss and is well tolerated in patients with recurrent weight gain after bariatric procedures, a small real-world observational study finds.

Distinct Courses in Primary and Secondary Empty Sella

Patients with primary and secondary empty sella show distinct clinical and endocrine trajectories over a median follow-up of about 5 years.

Does Tirzepatide Activate Brown Fat?

Tirzepatide seems to activate brown adipose tissue, potentially modulating energy expenditure at the tissue level in premenopausal women with obesity.

Semaglutide Linked to Fewer Fractures

In contrast to concerns of lean mass loss with GLP-1 receptor agonists, a large population-based study found lower fracture rates with semaglutide than with other weight-loss medications.

Novel Monoclonal Antibody Shows Benefit in Cushing Disease

The anti-adrenocorticotropic hormone antibody asedebart normalized urinary free cortisol in 7 of 8 study participants.

GLP-1s Aren’t a Solo Act. They Need Comprehensive Planning

Lifestyle changes, tracking, and support should go hand-in-hand with weight loss drugs.

AI Eye Scan Cuts Unneeded Diabetes Macular Edema Referrals

An AI-based OCT system integrated into standard diabetic retinopathy screening pathways reduces unwarranted referrals for diabetic macular edema, a recent study shows.

Recommended News For You

How a new light-based cancer treatment could destroy tumors without harming healthy cells—using LEDs

Mammo Responsibility Increases Screening; Opioids for Pain Related to Cancer? Ignored CRC Signs.

Hypnotherapy may offer real benefits for cancer patient care

Research exposes far-reaching toll of financial hardship on patients with cancer

Distribution of fat could influence cancer risk, study suggests

Launch of the hereditary cancer clinic for precision oncology at Kokilaben Hospital.

Top Options Are Discovered Through Direct Comparison of 25 Migraine Drugs.

Recommended Articles For You

Innovative Approaches in Oncology for Modern Medicine 

Clinical Trends in Oncology in Clinical Decision-Making 

Oncologic Emergencies: Diagnosis and Treatment 

Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

An inhibitor of JAK1 exhibits "remarkable" activity in T-cell lymphoma.

2.

In Biochemically Recurrent Nonmetastatic Prostate Cancer, Apalutamide Presents Its Argument.

3.

Decrease seen in in situ breast cancer since 2009

4.

Should the UK introduce targeted prostate cancer screening? The case for and against

5.

Safe and acceptable telehealth suicide prevention program.

1.

The Immunotherapeutic and Targeted Revolution in Melanoma Management – A 2025 Perspective

2.

How EPCORITAMAB is Revolutionizing the Treatment of Cancer

3.

Unraveling the Complexities of Embryonal Carcinoma: A New Hope for Treatment

4.

All You Need To Know About Melanoma Maligna: Causes, Symptoms & Treatment

5.

Targeting Iron Recycling Pathways in Hematologic Disease

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

2.

The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift

3.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation

4.

Dacomitinib Case Presentation: Baseline Treatment and Current Status

5.

Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot